DE69716094T2 - Bromotiacumicin verbindungen - Google Patents

Bromotiacumicin verbindungen

Info

Publication number
DE69716094T2
DE69716094T2 DE69716094T DE69716094T DE69716094T2 DE 69716094 T2 DE69716094 T2 DE 69716094T2 DE 69716094 T DE69716094 T DE 69716094T DE 69716094 T DE69716094 T DE 69716094T DE 69716094 T2 DE69716094 T2 DE 69716094T2
Authority
DE
Germany
Prior art keywords
bromotiacumicin
connections
bromotiacumicin connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69716094T
Other languages
English (en)
Other versions
DE69716094D1 (de
Inventor
E Hochlowski
Marianna Jackson
B Mcalpine
R Rasmussen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE69716094D1 publication Critical patent/DE69716094D1/de
Publication of DE69716094T2 publication Critical patent/DE69716094T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69716094T 1996-07-12 1997-06-24 Bromotiacumicin verbindungen Expired - Lifetime DE69716094T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/678,906 US5767096A (en) 1996-07-12 1996-07-12 Bromotiacumicin compounds
PCT/US1997/011064 WO1998002447A1 (en) 1996-07-12 1997-06-24 Bromotiacumicin compounds

Publications (2)

Publication Number Publication Date
DE69716094D1 DE69716094D1 (de) 2002-11-07
DE69716094T2 true DE69716094T2 (de) 2003-06-05

Family

ID=24724791

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716094T Expired - Lifetime DE69716094T2 (de) 1996-07-12 1997-06-24 Bromotiacumicin verbindungen

Country Status (20)

Country Link
US (1) US5767096A (de)
EP (1) EP0923594B1 (de)
JP (1) JP2000515512A (de)
KR (1) KR100476799B1 (de)
CN (1) CN1149220C (de)
AR (1) AR007854A1 (de)
AT (1) ATE225364T1 (de)
AU (1) AU730839B2 (de)
BR (1) BR9710250A (de)
CA (1) CA2257984A1 (de)
CZ (1) CZ294843B6 (de)
DE (1) DE69716094T2 (de)
DK (1) DK0923594T3 (de)
ES (1) ES2186900T3 (de)
HU (1) HU224966B1 (de)
IL (1) IL127540A (de)
NZ (1) NZ333258A (de)
PT (1) PT923594E (de)
WO (1) WO1998002447A1 (de)
ZA (1) ZA975861B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2860241A1 (de) * 2002-07-29 2015-04-15 Optimer Pharmaceuticals, Inc. Tiacumicinherstellung
US20070105791A1 (en) * 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
US7906489B2 (en) * 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
EP2305244B1 (de) * 2004-05-14 2016-10-12 Merck Sharp & Dohme Corp. Behandlung von Krankheiten im Zusammenhang mit der Anwendung von Antibiotika
AU2005327308B2 (en) * 2005-01-31 2011-11-10 Merck Sharp & Dohme Llc 18-membered macrocycles and analogs thereof
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
CN102115757B (zh) * 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
BR112015021501A2 (pt) * 2013-03-08 2017-07-18 Cipla Ltd composição farmacêutica, composição farmacêutica espumável, processo para fabricação de uma composição farmacêutica para administração retal, lata de aerossol para uma composição farmacêutica, uso de uma composição farmacêutica e método para tratar ou manter a remissão de infecções causadas por clostridium difficile
JP6579662B2 (ja) 2014-05-09 2019-09-25 アステラス ファーマ ユーロープ リミテッド チアクマイシン化合物の治療レジメン
EA034885B1 (ru) 2015-07-03 2020-04-02 Астеллас Фарма Юэроп Лтд. Новая схема лечения тиакумициновым соединением

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) * 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds

Also Published As

Publication number Publication date
HUP9903902A2 (hu) 2001-05-28
US5767096A (en) 1998-06-16
ZA975861B (en) 1998-01-30
IL127540A (en) 2004-05-12
CA2257984A1 (en) 1998-01-22
KR20000023662A (ko) 2000-04-25
CZ2899A3 (cs) 1999-03-17
BR9710250A (pt) 1999-08-10
WO1998002447A1 (en) 1998-01-22
JP2000515512A (ja) 2000-11-21
HUP9903902A3 (en) 2001-06-28
DE69716094D1 (de) 2002-11-07
ATE225364T1 (de) 2002-10-15
ES2186900T3 (es) 2003-05-16
IL127540A0 (en) 1999-10-28
DK0923594T3 (da) 2003-02-10
KR100476799B1 (ko) 2005-03-16
NZ333258A (en) 2000-07-28
EP0923594A1 (de) 1999-06-23
CZ294843B6 (cs) 2005-03-16
AR007854A1 (es) 1999-11-24
CN1225096A (zh) 1999-08-04
PT923594E (pt) 2003-02-28
CN1149220C (zh) 2004-05-12
AU730839B2 (en) 2001-03-15
EP0923594B1 (de) 2002-10-02
AU3504697A (en) 1998-02-09
HU224966B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
DE69528825D1 (de) Dendrime verbindungen
DE69733649D1 (de) Calcylitische verbindungen
DE69805769D1 (de) Entzündungshemmende verbindungen
FI960525A0 (fi) Framstaellning av mellandestillat
FI961551A0 (fi) Menylett utforming av kortmeddelanden
DE69518667T2 (de) Antiinflammatorische verbindungen
DE69716904T2 (de) Neue verbindungen
DE69807105T2 (de) Photochromische verbindungen
DE69716094T2 (de) Bromotiacumicin verbindungen
NO992932D0 (no) Innkapsling
FI960501A0 (fi) Foerfarande foer omkastning av uppkopplingsriktningen av samtal
DE29614220U1 (de) Anschlußgarnitur
DE69739606D1 (de) Ichten verbindungsstellen
DE59712516D1 (de) Chirale Verbindungen
FI961041A0 (fi) Klingledare av saogmaskin
FI960962A0 (fi) Foerfarande foer framstaellning av en flerskiktskartongprofil
ID17224A (id) Sediaan
NO962452D0 (no) Tannbehandlingssystem
FI960819A0 (fi) Foerfarande foer kollektiv inkassering av trafikavgifter
FI961569A0 (fi) Flerstegstrycksil foer silning av fibermassa
FI961733A0 (fi) Anordning foer sortering av virke
FI961474A0 (fi) Foerfarande foer stegloes bearbetning av signalen
FI960692A0 (fi) Foerfarande foer ansyrning av mjoelk
FI961483A0 (fi) Maetning av planhet
FI960621A0 (fi) Foerfarande foer rengoering av svaveldioxidhaltiga roekgaser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition